Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Investor press release · Financial statements
Turn Therapeutics Inc.
9
Investor press release
Jun 1, 2026
| ItemItem | Disclosure |
|---|---|
| Item 7.01 | Regulation FD disclosure (investor press release or presentation) |
| Item 9.01 | Financial statements and exhibits |
Turn Therapeutics Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. htm PRESS RELEASE, DATED JUNE 1, 2026 Exhibit 99. 1 Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis 92.
The filing reports Items 7.01, 9.01. None of these codes are typically workforce-tagged, but analysts still review them for indirect labor-market signals.
Turn Therapeutics Inc. filed this 8-K with the SEC. cutoffs links it to the employer's layoff history, visa filings, and other labor-market signals.
